1. Naive strategy:


Take all the hetero-assemblies that are on hold.
For each hetero-assembly:
   Take the sequences and assign them to a PDB 50 % sequence-cluster. Collect all the sequence-clusters thus assigned.
   For each sequence-cluster:
      Gather the list of PDB entries that belong to it. 
   If there is any PDB entry that is in *all* the lists, the hetero-assembly is redundant. If not, it is a potential CAPRI target.
   

2. Sameer's query to identify on-hold targets
(Aug 30: query result is stored in on-hold-targets.json, using wget -O)

https://www.ebi.ac.uk/pdbe/search/pdb/select?group=true&group.field=pdb_id&group.ngroups=true&json.nl=map&fl=*&rows=10000&start=0&q=(q_status%3Ahpub)%20OR%20(q_status%3Ahold)&fq=molecule_sequence:*&fq=number_of_polymer_entities:[2%20TO%20*]&group.limit=20&wt=json

3. Sameer's query to identify related sequences and their alignments
using phmmer:

https://www.ebi.ac.uk/pdbe/search/pdb/select?group=true&group.field=pdb_id&group.ngroups=true&json.nl=map&fl=pdb_id%2Ccitation_title%2Ccitation_authors%2Ctitle%2Cexperimental_method%2Centry_authors%2Cpubmed_id%2Ccitation_year%2Cjournal%2Corganism_scientific_name%2Cassembly_composition%2Cinteracting_ligands%2Ctax_id%2Cresolution%2Cstatus%2Crelease_date%2Cprefered_assembly_id%2Centry_author_list%2Centry_organism_scientific_name%2Cdata_quality%2Cmodel_quality%2Cexperiment_data_available%2Cdeposition_date%2Crelease_year%2Cmolecule_type%2Cpfam_name%2Cuniprot_coverage%2Ccompound_id%2Cbound_compound_id%2Cmodified_compound_id%2Cuniprot_accession_best%2Cinteracting_uniprot_accession&rows=10000&start=0&sort=phmmer(e_value)%20asc&xjoin_phmmer.fl=*&xjoin_phmmer=true&xjoin_phmmer.external.sequence=IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN&q=*:*&fq={!xjoin}xjoin_phmmer&group.limit=100&wt=json
(or generalized to $seq)
'https://www.ebi.ac.uk/pdbe/search/pdb/select?group=true&group.field=pdb_id&group.ngroups=true&json.nl=map&fl=pdb_id%2Ccitation_title%2Ccitation_authors%2Ctitle%2Cexperimental_method%2Centry_authors%2Cpubmed_id%2Ccitation_year%2Cjournal%2Corganism_scientific_name%2Cassembly_composition%2Cinteracting_ligands%2Ctax_id%2Cresolution%2Cstatus%2Crelease_date%2Cprefered_assembly_id%2Centry_author_list%2Centry_organism_scientific_name%2Cdata_quality%2Cmodel_quality%2Cexperiment_data_available%2Cdeposition_date%2Crelease_year%2Cmolecule_type%2Cpfam_name%2Cuniprot_coverage%2Ccompound_id%2Cbound_compound_id%2Cmodified_compound_id%2Cuniprot_accession_best%2Cinteracting_uniprot_accession&rows=10000&start=0&sort=phmmer(e_value)%20asc&xjoin_phmmer.fl=*&xjoin_phmmer=true&xjoin_phmmer.external.sequence='$seq'&q=*:*&fq={!xjoin}xjoin_phmmer&group.limit=100&wt=json'

(Aug 30: query result is stored in search-pdb-example.json, using wget -O)
(Another example search-pdb-6myo_[1=4].json using 6MYO, sequence
entry_entity molecule_sequence
6myo_1: STKVSDSISTQYPVVDHEFDAVVVGAGGAGLRAAFGLSEAGFNTACVTKLFPTRSHTVAAQGGINAALGNMEDDNWRWHFYDTVKGSDWLGDQDAIHYMTEQAPAAVIELENYGMPFSRTEEGKIYQRAFGGQSLQFGKGGQAHRCCCVADRTGHSLLHTLYGRSLRYDTSYFVEYFALDLLMENGECRGVIALCIEDGTIHRFRAKNTVIATGGYGRTYFSCTSAHTSTGDGTAMVTRAGLPCQDLEFVQFHPTGIYGAGCLITEGCRGEGGILINSQGERFMERYAPVAKDLASRDVVSRSMTIEIREGRGCGPEKDHVYLQLHHLPPQQLATRLPGISETAMIFAGVDVTKEPIPVLPTVHYNMGGIPTNYKGQVITHVNGEDKVVPGLYACGEAASASVHGANRLGANSLLDLVVFGRACALTIAETCKPGEPVPSIKPNAGEESVANLDKLRFADGTIRTSEARLNMQKTMQSHAAVFRTGSILQEGCEKLSQIYRDLAHLKTFDRGIVWNTDLVETLELQNLMLCALQTIYGAEARKESRGAHAREDYKLRIDEFDYSKPLQGQQKRPFEEHWRKHTLSYVDVKSGKVTLKYRPVIDRTLNEEDCSSVPPAIRSY
6myo_2: AQTAAAATSRIKKFSIYRWDPDKPGDKPRMQTYEVDLNKCGPMVLDALIKIKNELDSTLTFRRSCREGICGSCAMNIAGGNTLACTKKIDPDLSKTTKIYPLPHMYVVKDLVPDLSNFYAQYKSIEPYLKKKDESKQGKEQYLQSIEDRQKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDYTEERLAQLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKAAAA
6myo_3: MATTAKEEMARFWE(MLZ)NTKSSRPLSPHISIYKWSLPMAMSITHRGTGVALSLGVSLFSLAALLLPEQFPHYVAVVKSLSLSPALIYSAKFALVFPLSYHTWNGIRHLVWDMGKGFKLSQVEQSGVVVLILTLLSSAAIAAM
6myo_4: GSSKAASLHWTSERAVSALLLGLLPAAYLYPGPAVDYSLAAALTLHGHWGLGQVITDYVHGDTPIKVANTGLYVLSAITFTGLCYFNYYDVGICKAVAMLWSI

NOTE: modified amino acids (such as MTZ) need to be replaced in the query, e.g. by X


Detailed plan
====================
Obtain candidate targets using the on-hold entries in the PDB (query 1)

For every entity in every target, classify the entity:
   - Take molecule_sequence
   - Count all residues between (). These are nucleic acids or modified amino acids.
     However, first replace  "MSE" by M, ["HIE", "HIP", "HSD", "HSE"] by H
   - Classify the sequence as follows:      
      - length < 6, modified aa >= 50 % (cofactor (incl. sugars)) 
      - length >= 6, modified aa >= 50 % (nucleic acid)      
      - length < 30, modified aa 20-50 % (unnatural peptide)            
      - length <= 10, modified aa < 20 % (small peptide)
      - length 11-30, modified aa < 20 % (large peptide)
      - length > 30, modified aa 10-50 % (unnatural protein)
      - length > 30, modified aa 10-50 % (protein)
   - Filter the targets:
      - Remove all targets with nucleic acids, unnatural proteins and unnatural peptides
      - For now, remove all targets with large peptides (needs separate strategy)
      - Ignore all entities that are cofactors or small peptides (small peptides need separate strategy)
      - Remove all targets with less than two remaining entities
   
For each remaining target:
   For each entity:
      Identify related sequences using the sequence (query 2). 
      For each match:
         Reject all values with e>0.05
         Identify the region ("query_sequence_start/end")
         Classify them based on the seqid ("identity_percent")
          into "close" and "remote". For now, use 40% as the threshold.
      Merge all regions of all matches. Classify the coverage of the entity:
      - Complete: One contiguous region of more than 20 aa. 
         N- and C-ter gaps <= 50 aa each.
      - Contiguous: One contiguous region. N- and/or C-ter gap >50 aa.
      - Multi-domain: Multiple contiguous regions. 
         Gaps between them are <= 20 aa each.  
      - Bad:
          No region of more than 20 aa. 
          OR: Multiple contiguous regions. 
            with gaps in the middle of more than 20 aa each, 

   Reject any target with any entity with bad coverage.
   For now, also reject multi-domain coverage (requires separate strategy)
   For now, treat contiguous coverage as complete. Inquiry with the experimental
    group is necessary to make sure that no important domain is missing.

   For each pair of matches:
      Check if they are compatible. Matches are compatible if:
      - They have the same PDB ID ("joinId")
      - They are superimposable, because their region shares at least 20 amino acids
      NOTE: This strategy will not work if there is internal homology *within* the target.
      In that case, two regions will match the same region in the matching PDB.
      This could be detected, but I do not know of a correct strategy once this happens

   Merge all compatible close matches into groups. A group consist of 
   regions for one or more entities, and one or more PDB ids.
   
   A target is trivial if at least one PDB or group contains a continuous 20 amino acid region 
    for all entities.
   
   Else, merge all compatible close and non-close matches into groups. If there is only
    one group, classify the target as "template-based", else as "ab initio".
   If there are more than two groups, classify the target as "multi-body".

   